Fortitude Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09K | Buy |
38
+17
| +81% | +$935 | ﹤0.01% | 1176 |
|
|
2025
Q1 | $1.48K | Hold |
21
| – | – | ﹤0.01% | 968 |
|
|
2024
Q4 | $1.38K | Buy |
+21
| New | +$1.38K | ﹤0.01% | 1085 |
|
|
2024
Q2 | – | Sell |
-9
| Closed | -$786 | – | 976 |
|
|
2024
Q1 | $786 | Sell |
9
-32
| -78% | -$2.8K | ﹤0.01% | 912 |
|
|
2023
Q4 | $3.95K | Buy |
+41
| New | +$3.95K | ﹤0.01% | 768 |
|